These findings suggest that increased LDL oxidation to OXLDL in obesity contributes to vascular impairment, likely due to increased oxidative stress and inflammation mediated by elevated MPO and CRP. The gene discussed is MPO; the disease is obesity due to melanocortin 4 receptor deficiency.